达比加群脂杂质C

达比加群脂杂质C性质、用途与生产工艺

用途

达比加群脂杂质用于药品达比加群脂的合成制备中，也用作杂质对照品。

达比加群脂杂质C 上下游产品信息

上游原料

下游产品

达比加群脂杂质C 生产厂家

1408238-40-3, 达比加群脂杂质C 相关搜索:

• benzimidazol
• Dabigatran impurity
• 杂质-达比加群酯
• 杂质对照品
• 有机中间体
• 对照品-杂质对照品
• 杂质
• C34H40N6O6
• N-[[2-[[[4-[[[(己氧基)羰基]氨基]羰基]苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-B-丙氨酸乙酯
• 3-(2-(((4-(((己基氧基)羰基)氨基甲酰基)苯基)氨基)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[D]咪唑-5-甲酰胺基)丙酸乙酯
• BIBR1154,达比加群酯 杂质对照品
• N-[[2-[[[4-[[[(己氧基)羰基]氨基]羰基]苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基 -Β-丙氨酸乙酯
• 达比加群酯杂质1514
• 达比加群酯杂质186
• Β-?ALANINE, N-?[[2-?[[[4-?[[[(HEXYLOXY)?CARBONYL]?AMINO]?CARBONYL]?PHENYL]?AMINO]?METHYL]?-?1-?METHYL-?1H-?BENZIMIDAZOL-?5-?YL]?CARBONYL]?-?N-?2-?PYRIDINYL-?, ETHYL ESTER
• 达比加群脂杂质C
• N-[[2-[[[4-[[[(HEXYLOXY)CARBONYL]AMINO]CARBONYL]PHENYL]AMINO]METHYL]-1-METHYL-1H-BENZIMIDAZOL-5-YL]CARBONYL]-N-2-PYRIDINYL-Β-ALANINE ETHYL ESTER
• N-[[2-[[[4-[[[(己氧基)羰基]氨基]羰基]苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-BETA-丙氨酸乙酯
• 达比加群酯杂质 E BIBR 1154 BS
• 达比加群杂质7(DABRC-07)
• 达比加群酯标准品009
• 达比加群杂质8
• 原研代码BIBR1154
• 1408238-40-3
• Dabigatran Impurity 9
• N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-b-alanine Ethyl Ester
• Desethyl Dabigatran Etexilate Impurity F
• N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester
• BIBR1154, Dabigatran Etexilate impurity
• Dabigatran Etexilate Amid Analogon (Ethyl 3-[[2-[[4-(Hexoxycarbonylcarbamoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-(2-pyridyl)amino]propanoate)
• Etexilate Amide Impurity
• Dabigatran etexilate impurity13
• Dabigatran etexilate impurity1514
• Dabigatran etexilate impurity186
• Dabigatran Amide Impurity
• β-?Alanine,N-?[[2-?[[[4-?[[[(hexyloxy)?carbonyl]?amino]?carbonyl]?phenyl]?amino]?methyl]?-?1-?methyl-?1H-?benzimidazol-?5-?yl]?carbonyl]?-?N-?2-?pyridinyl-?,ethylester
• -alanineEthylEster
• Dabigatran JPBA Impurity 10
• Dabigatran etexilate Imp.C
• N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester
• EBASTINE IMPURITY A
• Dabigatran etexilate-009
• Dabigatran Impurity 7 (DABRC-07)
• Dabigatran etexilate-4
• Dabigatran Impurity 3/Dabigatran Etexilate Amid Analogon/Desiminomethyl Carbonyl Dabigatran Etexilate/N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester
• ethyl 3-[[[2-[[[4-[[[(hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino]propanoate
• N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester
• Dabigatran Ester Impurity C
• Desiminomethyl Carbonyl Dabigatran Etexilate
• Dabigatran Impurity c
• Dabigatran Impurity 8
• β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester